Results 161 to 170 of about 297,519 (217)

The Role of Natural Killer (NK) Cells in Dengue Virus Infection: A Narrative Review. [PDF]

Health Sci Rep
Islam F.
europepmc   +1 more source

Climate change and budget cuts: Facing the <i>Aedes</i> and <i>Anopheles</i> challenges together. [PDF]

Malariaworld J
MacDonald M.
europepmc   +1 more source

Pre-Travel Consultation for the Prevention of Infectious Diseases among International Travelers from GCC Countries: Travel Medicine Recommendations for Clinicians. [PDF]

Saudi J Med Med Sci
Barry M, Al-Tawfiq JA, Farahat F, Alzunitan M, Almaziad S, Alshamrani M, Memish ZA.   +6 more
europepmc   +1 more source

Bridging the Gaps in Dengue Control in Latin America: Multisectoral Strategies from an Expert Panel. [PDF]

Vaccines (Basel)
Tejada CE, Aizenberg M, Cucunubá Z, Rodríguez WC, Bazán JD, Terrón FAG, Gutiérrez G, Cuentas AL, Casapia Morales M, Núñez JGM, Mojica JA, Orduna T, Pando-Robles V, Rico-Restrepo M, Torres JR, Soto MJV, Vélez ID.   +16 more
europepmc   +1 more source

Parameters Affecting Dengue Virus Replication in Vero Cells. [PDF]

Vaccine X
Asim MMH, Khan AM, Susmi TF, Mahmud FMA, Zubayer A, Mozid MT, Rayhan R, Ashik MMR, Nasrin S, Khan I, Karim M, Muktadir H, Muktadir A, Whitehead SS, Ahasan MM.   +14 more
europepmc   +1 more source

TAK-003 Dengue Vaccine Safety: Evidence from a Systematic Review and Meta-analysis of Clinical Trials. [PDF]

Indian J Community Med
Kumar R, Singh S, Maharshi V.
europepmc   +1 more source

Optimizing dengue vaccination strategies. [PDF]

PLoS Med
Wilder-Smith A.
europepmc   +1 more source

Safety of the Dengue Vaccine TAK-003 and Factors Associated with Adverse Events in Travellers from Non-Endemic Areas: A Real-World Prospective Multicentre Pharmacovigilance Cohort Study in Spain. [PDF]

Lancet Reg Health Eur
Camprubí-Ferrer D, Bertran-Cobo C, Valerio L, Saloni M, González Nieto I, López López V, Garcia D, Jurado E, Machado ML, Pérez-León D, Cuevas Marín S, Subirà C, Villar-García J, Herena García D, Ayala Cortés SN, Sànchez Casado M, Gomila-Grange A, Flores C, Morales Llorente N, Górriz Hidalgo E, Morales Martínez RM, Vila F, Martín N, Muñoz J, CATdenga study groupm, CATdenga study group.   +25 more
europepmc   +1 more source

1-Year follow-up evaluation of TAK-003 dengue vaccine effectiveness against symptomatic disease and hospitalisation in adolescents during the 2024-2025 outbreak in São Paulo, Brazil: a test-negative case-control study. [PDF]

EClinicalMedicine
Krug Mareto L, Brumatti TS, Dias de Oliveira R, Vieira da Silva P, Ribeiro Dos Santos E, D'Agostini TL, Cardoso De Paula RA, Dean NE, Ko AI, Cummings DAT, Andrews JR, Hitchings MDT, Ranzani O, Croda J.   +13 more
europepmc   +1 more source

Design of a novel epitope-based tetravalent subunit vaccine against dengue virus: An immunoinformatic approach. [PDF]

PLoS One
Ferdousy TJ, Hasan Miraz MM, Al Arian T, Afif Ullah M, Risat MTH, Akter MA, Kundu S, Sarkar BK, Sarkar AP, Khalipha ABR, Kundu SK.   +10 more
europepmc   +1 more source